Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (greater than 4 cm) - T4 N0-3 M0 or Any T N2-3 M0
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2017
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil (Primary) ; Mitomycin (Primary)
- Indications Anal cancer
- Focus Adverse reactions
- 06 Mar 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Jan 2019.
- 18 Nov 2015 Results published in the European Journal of Cancer
- 02 Sep 2015 According to the the ClinicalTrials.gov record, planned end date changed to 1 Jul 2017.